Byfavo

Chemical Nameremimazolam
Dosage FormInjection (iIntravenous; 20 mg)
Drug ClassBenzodiazepines
SystemOther
CompanyAcacia Pharma, Inc.
Approval Year2020

Indication

  • For the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
Last updated on 12/7/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Byfavo (remimazolam) Prescribing Information.2020Acacia Pharma, Inc. Indianapolis, IN